Life Science Institute LLC
04/16/2024 | Press release | Distributed by Public on 04/16/2024 13:51
Annual Report by Private Issuer - Form C-AR
| FORM C |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 |
OMB APPROVAL |
|
|
OMB Number: ####-#### Estimated average burden hours per response: ##.# |
Form C: Filer Information
| Filer CIK: |
0001873475
|
| Filer CCC: |
XXXXXXXX
|
| Period: |
12-31-2023
|
| Is this a LIVE or TEST Filing? | LIVE TEST |
| Is this an electronic copy of an official filing submitted in paper format in connection with a hardship exemption? | |
| Would you like a Return Copy? |
Submission Contact Information
| Name: |
|
| Phone Number: |
|
| Contact E-Mail Address: |
|
| Notify via Filing Website only? |
Form C: Issuer Information
Issuer Information
| Name of Issuer: |
Life Science Institute LLC
|
Legal Status of Issuer:
| Form: |
Limited Liability Company
|
| Jurisdiction of Incorporation/Organization: |
DELAWARE
|
| Date of Incorporation/Organization: |
01-24-2012
|
Physical Address of Issuer:
| Address 1: |
3301 Salterbeck Street, Suite 102
|
| City: |
Mount Pleasant
|
| State/Country: |
SOUTH CAROLINA
|
| Mailing Zip/Postal Code: |
29466
|
| Website of Issuer: |
https://www.healthycell.com/
|
Form C: Annual Report Disclosure Requirements
Annual Report Disclosure Requirements
| Current Number of Employees: |
7
|
| Total Assets Most Recent Fiscal Year-end: |
2717035.00
|
| Total Assets Prior Fiscal Year-end: |
4131353.00
|
| Cash and Cash Equivalents Most Recent Fiscal Year-end: |
492156.00
|
| Cash and Cash Equivalents Prior Fiscal Year-end: |
1653471.00
|
| Accounts Receivable Most Recent Fiscal Year-end: |
163708.00
|
| Accounts Receivable Prior Fiscal Year-end: |
133769.00
|
| Short-term Debt Most Recent Fiscal Year-end: |
2199664.00
|
| Short-term Debt Prior Fiscal Year-end: |
2393985.00
|
| Long-term Debt Most Recent Fiscal Year-end: |
491722.00
|
| Long-term Debt Prior Fiscal Year-end: |
514679.00
|
| Revenue/Sales Most Recent Fiscal Year-end: |
7610155.00
|
| Revenue/Sales Prior Fiscal Year-end: |
5647592.00
|
| Cost of Goods Sold Most Recent Fiscal Year-end: |
2448039.00
|
| Cost of Goods Sold Prior Fiscal Year-end: |
1859293.00
|
| Taxes Paid Most Recent Fiscal Year-end: |
0.00
|
| Taxes Paid Prior Fiscal Year-end: |
0.00
|
| Net Income Most Recent Fiscal Year-end: |
-1896403.00
|
| Net Income Prior Fiscal Year-end: |
-1402751.00
|
Form C: Signature
Signature
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), the issuer certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form C and has duly caused this Form to be signed on its behalf by the duly authorized undersigned.| Issuer: |
Life Science Institute, LLC d/b/a Healthycell
|
| Signature: |
Douglas V. Giampapa
|
| Title: |
CEO
|
Pursuant to the requirements of Sections 4(a)(6) and 4A of the Securities Act of 1933 and Regulation Crowdfunding (§ 227.100-503), this Form C has been signed by the following persons in the capacities and on the dates indicated.
| Signature: |
Douglas V. Giampapa
|
| Title: |
CEO
|
| Date: |
04-16-2024
|